Mimetas
Leiden, Netherlands
Mimetas specializes in human tissue models for advanced drug discovery using their proprietary Organ-on-a-Chip platform. They provide 3D tissue models that replicate human physiology, including perfused vasculature and immune elements, to enhance drug efficacy and safety testing. Their solutions aim to reduce reliance on animal testing while delivering predictive data for pharmaceutical research. Offering products like OrganoPlate and services such as CRO, they target pharmaceutical companies and researchers across various therapeutic areas to accelerate decision-making and de-risk drug development pipelines through robust, reproducible biological data.
Company Info
- Founded
- 2013
- Website
- www.mimetas.com
Only accessible to MedStartr community members.
Join nowWhat do you think of Mimetas?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.